Your browser doesn't support javascript.
loading
A randomized, open-label, dose-response study of losartan in hypertensive children.
Webb, Nicholas J A; Wells, Thomas G; Shahinfar, Shahnaz; Massaad, Rachid; Dankner, Wayne M; Lam, Chun; Santoro, Emanuela Palumbo; McCrary Sisk, Christine; Blaustein, Robert O.
Affiliation
  • Webb NJ; Department of Paediatric Nephrology and National Institute for Health Research/Wellcome Trust Children's Clinical Research Facility, University of Manchester, Manchester Academic Health Science Centre, Royal Manchester Children's Hospital, Manchester, United Kingdom; nicholas.webb@cmft.nhs.uk.
  • Wells TG; Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas;
  • Shahinfar S; S. Shahinfar Consulting Inc., Newtown Square, Pennsylvania; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;
  • Massaad R; MSD Europe Inc., Brussels, Belgium;
  • Dankner WM; Parexel International, Durham, North Carolina; and.
  • Lam C; Merck & Co., Inc., Whitehouse Station, New Jersey.
  • Santoro EP; Merck & Co., Inc., Whitehouse Station, New Jersey.
  • McCrary Sisk C; Merck & Co., Inc., Whitehouse Station, New Jersey.
  • Blaustein RO; Merck & Co., Inc., Whitehouse Station, New Jersey.
Clin J Am Soc Nephrol ; 9(8): 1441-8, 2014 Aug 07.
Article in En | MEDLINE | ID: mdl-24875194

Full text: 1 Database: MEDLINE Main subject: Blood Pressure / Losartan / Angiotensin II Type 1 Receptor Blockers / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Diagnostic_studies Language: En Journal: Clin J Am Soc Nephrol Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: Blood Pressure / Losartan / Angiotensin II Type 1 Receptor Blockers / Hypertension / Antihypertensive Agents Type of study: Clinical_trials / Diagnostic_studies Language: En Journal: Clin J Am Soc Nephrol Year: 2014 Type: Article